Barriers and outcomes: TB patients co-infected with HIV accessing antiretroviral therapy in rural Zambia

被引:38
|
作者
Chileshe, Muatale [1 ,2 ]
Bond, Virginia Anne [1 ,3 ]
机构
[1] ZAMBART Project, Sch Med, Lusaka, Zambia
[2] Univ Cape Town, ZA-7925 Cape Town, South Africa
[3] LSHTM, Hlth Policy Unit, Fac Publ Hlth & Policy, London WC1E 7HT, England
来源
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV | 2010年 / 22卷
关键词
TB; HIV; Zambia; ART; food security; RESOURCE-POOR SETTINGS; ADHERENCE; TANZANIA; PROGRAM; KISESA;
D O I
10.1080/09540121003617372
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The vulnerabilities that underlie barriers faced by the rural poor whilst trying to access and adhere to "free'' antiretroviral treatment (ART) demand more attention. This paper highlights barriers that poor rural Zambians co-infected with tuberculosis (TB) and HIV and their households faced in accessing ART between September 2006 and July 2007, and accounts for patient outcomes by the end of TB treatment and (more sporadically) beyond October 2009. The analysis draws on findings from wider anthropological fieldwork on the converging impact of TB, HIV and food insecurity, focusing for the purpose of this paper on ethnographic case-studies of seven newly diagnosed TB patients co-infected with HIV and their six households (one household had two TB patients). Economic barriers included being pushed into deeper poverty by managing TB, rural location, absence of any external assistance, and mustering time and extended funds for transport and "special food'' during and beyond the end of TB. In the case of death, funeral costs were astronomical. Social barriers included translocation, broken marriages, a sub-ordinate household position, gender relations, denial, TB/HIV stigma and the difficulty of disclosure. Health facility barriers involved understaffing, many steps, lengthy procedures and inefficiencies (lost blood samples, electricity cuts). By the end of TB treatment, outcomes were mixed; two co-infected patients had died, three had started ART and two had yet to start ART. The three on ART underwent a striking transformation in the short term. By October 2009, two more had died and three were doing well. The study advocates nutritional support and other material support (especially transport funds) for co-infected TB patients until ART is accessed and livelihood regained. More prompt diagnosis of TB and reducing steps and increasing the reach of the ART programme in rural areas are also recommended.
引用
收藏
页码:51 / 59
页数:9
相关论文
共 50 条
  • [31] Treatment outcome and mortality: Their predictors among HIV/TB co-infected patients from Iran
    Tabarsi, Payam
    Chitsaz, Ehsan
    Moradi, Ahmadreza
    Baghaei, Parvaneh
    Marjani, Majid
    Mansouri, Davood
    INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY, 2012, 1 (02) : 82 - 86
  • [32] Barriers to the care of HIV-infected children in rural Zambia: a cross-sectional analysis
    van Dijk, Janneke H.
    Sutcliffe, Catherine G.
    Munsanje, Bornface
    Hamangaba, Francis
    Thuma, Philip E.
    Moss, William J.
    BMC INFECTIOUS DISEASES, 2009, 9 : 169
  • [33] Hepatitis C virus modulates IgG glycosylation in HIV co-infected antiretroviral therapy suppressed individuals
    Giron, Leila B.
    Azzoni, Livio
    Yin, Xiangfan
    Lynn, Kenneth M.
    Ross, Brian N.
    Fair, Matthew
    Damra, Mohammad
    Sciorillo, Amanda C.
    Liu, Qin
    Jacobson, Jeffrey M.
    Mounzer, Karam
    Kostman, Jay R.
    Abdel-Mohsen, Mohamed
    Montaner, Luis J.
    Papasavvas, Emmanouil
    AIDS, 2020, 34 (10) : 1461 - 1466
  • [34] Nonadherence to antiretroviral therapy among HIV infected patients in Zambia is concentrated among a minority of patients and is highly variable across clinics
    Czaicki, Nancy L.
    Holmes, Charles B.
    Sikazwe, Izukanji
    Bolton, Carolyn
    Savory, Theodora
    Mwanza, Mwanza Wa
    Moyo, Crispin
    Padian, Nancy S.
    Geng, Elvin H.
    AIDS, 2017, 31 (05) : 689 - 696
  • [35] Tuberculosis treatment outcomes of diabetic and non-diabetic TB/HIV co-infected patients: A nationwide observational study in Brazil
    Villalva-Serra, Klauss
    Barreto-Duarte, Beatriz
    Nunes, Vanessa M.
    Menezes, Rodrigo C.
    Rodrigues, Moreno M. S.
    Queiroz, Artur T. L.
    Arriaga, Maria B.
    Cordeiro-Santos, Marcelo
    Kritski, Afranio L.
    Sterling, Timothy R.
    Araujo-Pereira, Mariana
    Andrade, Bruno B.
    FRONTIERS IN MEDICINE, 2022, 9
  • [36] Optimal therapy of HIV/HCV co-infected patients with direct acting antivirals
    Rockstroh, Juergen K.
    LIVER INTERNATIONAL, 2015, 35 : 51 - 55
  • [37] Effect of oral immunomodulator Dzherelo in TB/HIV co-infected patients receiving anti-tuberculosis therapy under DOTS
    Nikolaeva, Lyudmila G.
    Maystat, Tatyana V.
    Pylypchuk, Volodymyr S.
    Volyanskii, Yuri L.
    Masyuk, Lilia A.
    Kutsyna, Galyna A.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2008, 8 (06) : 845 - 851
  • [38] Prevalence of parasitemia and associated immunodeficiency among HIV-malaria co-infected adult patients with highly active antiretroviral therapy
    Omoti, Caroline E.
    Ojide, Chiedozie K.
    Lofor, Patrick V.
    Eze, Emeka
    Eze, Joy C.
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2013, 6 (02) : 126 - 130
  • [39] Delayed HIV treatment, barriers in access to care and mortality in tuberculosis/HIV co-infected patients in Cali, Colombia
    Gonzalez-Duran, Jorge A.
    Plaza, Regina, V
    Luna, Lucy
    Arbelaez, Maria Patricia
    Deviaene, Meagan
    Keynan, Yoav
    Rueda, Zulma Vanessa
    Marin, Diana
    COLOMBIA MEDICA, 2021, 52 (04):
  • [40] Time to death predictors of HIV/AIDS infected patients on antiretroviral therapy in Ethiopia
    Tadege M.
    BMC Research Notes, 11 (1)